Darwin (7V0.DE) Stock Price

Darwin Price

CLOSED
6.00
​
Market closed

Revenue at Darwin has contracted by 16.4% per year over the past 4 years to 54.30 M EUR. Earnings per share have declined at 71.0% per year over the last 4 years. For Darwin, the net margin of 1.0% is down versus 17.4% a few years ago. At today's price the dividend yield works out to roughly 9.38%. The dividend has grown at 8.7% per year over the past 3 years. The consensus 12-month price target for Darwin is 22.44 EUR, about 274.0% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Darwin stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Darwin business model & stock analysis

Darwin AG generates revenue through the development and sale of dietary supplements and cosmetics products. The company leverages biotechnology and AI to create personalized solutions based on scientific lab analysis data. Its fully licensed laboratories offer genetic and metabolomic testing services, including lifestyle personal genomics and embryo screening during IVF to improve success rates. These services are provided to clients seeking personalized health and wellness solutions. The firm's products and services target individuals interested in personalized health, including those undergoing IVF treatments. The company's focus on genetic and metabolomic testing enables it to provide tailored recommendations for dietary supplements and cosmetics. This approach aligns with the growing demand for data-driven health and wellness products in the market. Darwin AG's business model integrates advanced biotechnology with AI to analyze genetic materials, which informs the development of its product lines. The company's fully licensed laboratories ensure compliance and quality in all testing services. Revenue streams are derived from both product sales and service-based offerings, catering to a segment of consumers prioritizing personalized health solutions.

Frequently asked questions about Darwin

Analysts currently set an average price target of 22.44 EUR for the Darwin stock (median: 22.44 EUR), implying +274.0 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Darwin stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Darwin to generate revenue of 57.25 M EUR and earnings per share of 0.04 EUR.

The expected revenue of Darwin is 57.25 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Darwin is 481,163.98 EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Darwin is currently 149.64. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Darwin stock.

The price-to-sales ratio (P/S) of Darwin is currently 1.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Darwin stock.

The Eulerpool Quality Score for Darwin is 3/10.

The ISIN of Darwin is DE000A3C35W0. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Darwin is A3C35W. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Darwin is 7V0.DE. The ticker symbol is used to trade Darwin shares on the stock exchange.

Fair ValueTerminal
6.24 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
EUR
Initial public offering
Nov 2, 2021
ISIN
DE000A3C35W0
Cusip
D5S2AY105
Market capitalization
72.00 M EURMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
149.64
P/Ee 2027
9.81
P/S
P/Se
1.26
EV/EBIT
—
P/B Ratio
0.72
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.53 %
Dividend
Dividend yield
9.38 %
Est. Dividend Yield
10.19 %
Payout Ratio
1,237.48 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
4 years
Dividend not reduced since
4 years
Dividend increased since
0 years
Dividend withholding tax
26.38 %
Last updated Nov 18, 2026, 10:40 PM

Darwin Peer Group

Darwin FIGI

7V0:GR · BBG0137Y8NH37V0:GF · BBG0137Y8NJ17V0:GY · BBG0137Y8NL87V0:GM · BBG0137Y8NN67V0EUR:XS · BBG013B91BH67V0EUR:X2 · BBG013B91BJ47V0EUR:XH · BBG013B91BL17V0EUR:XF · BBG013B91BN97V0EUR:XE · BBG013B91BQ67V0EUR:XJ · BBG013B91BR57V0EUR:XL · BBG013B91BS47V0EUR:XG · BBG013B91BT3

All fundamentals and in-depth analysis of Darwin

Our stock analysis for Darwin stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Darwin. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.